Oscar G. Segurado, MD

Chief Medical Officer
ASC Therapeutics

Gil Gonen-Yaacovi, PhD, is Associate Director, Clinical and Regulatory Affairs at ASC Therapeutics. Dr. Gonen-Yaacovi has extensive experience in managing clinical trials and has conducted different regulatory submissions to multiple authorities. ASC Therapeutics is a biopharmaceutical company, based in Milpitas, CA, focused on gene therapy, gene editing, and cell therapy in multiple indications.

Presentation(s):

• PB0662 - Clinical Study of Adenovirus-Associated Viral Vector-Mediated Gene Therapy of Human Factor VIII in Severe and Moderately Severe Hemophilia A

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PO0017 - Essential Biomarkers for a Clinical Study of a Novel Allogeneic Cell Therapy for Acute Graft-versus-Host Disease

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM